Article
Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Antimicrobial agents and chemotherapy - 1 Feb 2011
Piret Jocelyne, Boivin Guy
Abstract excerpt
Herpes simplex viruses (HSV) type 1 and type 2 are responsible for recurrent orolabial and genital infections. The standard therapy for the management of HSV infections includes acyclovir (ACV) and penciclovir (PCV) with their respective prodrugs valacyclovir and famciclovir. These compounds are phosphorylated by the viral thymidine kinase (TK) and then by cellular kinases. The triphosphate forms selectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
